Daniel Teupser

Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial

Dirk Sibbing, Dániel Aradi, Claudius Jacobshagen et al. · The Lancet · 2017 · 571 citations · Full text

Percutaneous Coronary Intervention, Thrombosis, Cardiovascular Disease +11

Simultaneous quantification of seven repurposed COVID-19 drugs remdesivir (plus metabolite GS-441524), chloroquine, hydroxychloroquine, lopinavir, ritonavir, favipiravir and azithromycin by a two-dimensional isotope dilution LC–MS/MS method in human serum

Katharina Habler, Mathias Brügel, Daniel Teupser et al. · Journal of Pharmaceutical and Biomedical Analysis · 2021 · 90 citations · Full text

Therapeutic Drug Monitoring, Pharmacology, Antiviral Drug Development +12

Fibroblast growth factor receptor signalling is crucial for liver homeostasis and regeneration

Heike Steiling, Torsten Wüstefeld, Philippe Bugnon et al. · Oncogene · 2003 · 85 citations

Regenerative Medicine, Fibrosis, Developmental Biology +11

Comparison of five automated hematology analyzers in a university hospital setting: Abbott Cell-Dyn Sapphire, Beckman Coulter DxH 800, Siemens Advia 2120i, Sysmex XE-5000, and Sysmex XN-2000

Mathias Bruegel, Dorothea Nagel, Manuela Funk et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 2015 · 79 citations

S100B and NSE as Useful Postmortem Biochemical Markers of Traumatic Brain Injury in Autopsy Cases

Benjamin Ondruschka, Dirk Pohlers, Gerald Sommer et al. · Journal of Neurotrauma · 2013 · 48 citations